Helen of Troy (HELE) Q1 2026 Earnings Call July 10, 2025 09:00 AM ET Company ParticipantsAnne Rakunas - Director - External CommunicationsBrian Grass - CEOTracy Schuerman - CFOOlivia Tong - Managing DirectorSusan Anderson - Managing DirectorConference Call ParticipantsRupesh Parikh - MD & Senior AnalystPeter Grom - Equity Research AnalystOperatorGreetings. Welcome to the Helen of Troy Limited First Quarter twenty twenty six Earnings Call. At this time, all participants are in a listen only mode. A question ...

Mental illnesses that do not respond to standard treatment could be hormone-driven https://t.co/5QxNqpKH9s ...

RENO, N.V., July 10, 2025 (GLOBE NEWSWIRE) -- GreetEat Corporation (OTC: GEAT), a fast-growing innovator in digital social and financial platforms, today announced significant increases in user engagement across its flagship properties, GreetEat.com and WallStreetStats.io - a clear validation of its dual-focus strategy on virtual connection and intelligent investing. GreetEat.com, the company’s breakthrough platform blending food delivery with immersive video conferencing, continues to redefine how people c ...

Core Insights - Fifty1 AI Labs, LLC has successfully completed the REVIVE Adaptive Platform Trial, the largest Long COVID study to date, addressing a health crisis affecting approximately 400 million people globally and 15% of COVID-19 survivors, with an economic burden exceeding USD 1 trillion annually [1][2] - The trial demonstrates a clear treatment benefit for Long COVID, aligning with Fifty 1 Labs, Inc.'s vision to revolutionize healthcare through AI-driven drug repurposing and functional medicine, targeting the $5.68 trillion biotech market [2][3] - The company aims to achieve a $50 million valuation and lead the $320.6 billion functional medicine market, enhancing investor confidence and positioning for uplisting to OTCQB by Q1 2026 and NASDAQ in the coming years [2][7] Company Achievements - The REVIVE Trial enrolled over 600 participants, achieving the fastest recruitment for a study of its kind, showcasing operational excellence and strategic partnerships with leading institutions [3][4] - Fifty1 AI Labs' proprietary AI platform, supported by a $1 million R&D investment, optimizes drug candidate selection and accelerates clinical research efficiency, setting a new standard in the industry [4][5] - The findings from the REVIVE Trial are expected to establish a foundation for polypharmacy-based treatment regimens, unlocking significant opportunities for intellectual property development and potential annual revenue in the billions [5][6] Strategic Initiatives - The company is pursuing regulatory pathways to bring novel therapies to market and establishing R&D hubs in Vancouver, alongside strategic partnerships with pharmaceutical leaders [7] - Upcoming initiatives include the launch of a minimum viable product website by July 24, 2025, and a fully interactive website by July 31, 2025, aimed at enhancing investor engagement [7] - A virtual shareholder teleconference is scheduled for July 28, 2025, to provide insights into the company's transformative vision and progress toward uplisting [7]

NEWTON, Mass., July 10, 2025 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets soluble amyloid beta oligomers (AβOs) for the treatment of Alzheimer's disease (AD), will present new findings at the upcoming Alzheimer's Association International Conference (AAIC®) 2025 in Toronto. The presentations include a cost savings analysis of the use of pTau217 as a screening tool in Acumen's Phase 2 ALTITUDE-AD trial ...

On track for CTA submission in Q4 2025 ETX-312 well tolerated at exaggerated dose levels in GLP-compliant toxicology studies GMP manufacturing of clinical trial batch successfully completed LONDON, July 10, 2025 (GLOBE NEWSWIRE) -- e-therapeutics plc, a company integrating computational power and biological data to discover life-transforming RNAi medicines, today announced significant progress on its lead candidate, ETX-312, a GalOmic siRNA therapy for the treatment of metabolic dysfunction- associated stea ...

1. 统一的会员体系 2. 线上线下库存同步 3. 增强现实(AR)和虚拟现实(VR) 在社交电商环境中，O2O（Online to Offline/Offline to Online）融合模式旨在通过线上平台与线下实体店铺的互动，为消费者提供无缝连接的购 物体验。这种模式不仅能够提升用户体验，还能帮助商家扩大市场覆盖范围和提高运营效率。以下是探索社交电商中O2O融合模式的一些关键 策略： 实时更新：确保线上商城与实体店之间的库存信息实时同步，避免出现缺货或超卖的情况。 智能补货系统：利用大数据分析预测需求，自动调整库存水平，优化供应链管理。 虚拟试穿/试用：通过AR技术让用户在家就能"试穿"衣服或"试用"化妆品，减少退货率并提升购买决策的速度。 店内导航：使用VR技术为用户提供虚拟店内的导航服务，帮助他们快速找到所需商品。 KOL合作：与关键意见领袖(KOLs)合作，通过直播、短视频等形式推广产品，引导粉丝到线下门店体验或购买。 UGC内容创作：鼓励用户生成内容(User Generated Content)，如晒单、评价等，并分享至社交媒体，形成口碑传播。 同城配送：对于靠近实体店的订单，可以提供"即日达 ...

Key Takeaways RXRX acquired Rallybio's full stake in the joint HPP program, including REV102 and a backup molecule. The deal allows RXRX to accelerate the development of REV102 using its Recursion OS AI platform for HPP. REV102 is a selective ENPP1 inhibitor with strong preclinical safety data; phase I studies begin in late 2026.Shares of Recursion Pharmaceuticals (RXRX) gained 8.7% on Tuesday and continue to gain today. The uptrend was triggered after it announced acquiring Rallybio’s (RLYB) full interes ...

Key Takeaways Fortinet outperforms Check Point in network security stock comparison with stronger growth. FTNT shares gained 11.6% in three months while CHKP returned 5.8% in same period. Fortinet's SASE strategy and firewall refresh cycle position it for 2025 growth.The cybersecurity landscape continues to evolve rapidly, with network security remaining a critical priority for enterprises worldwide. Two industry stalwarts, Fortinet (FTNT) and Check Point Software Technologies (CHKP) , have established th ...

A Media Snippet accompanying this announcement is available by clicking on this link. LONDON, July 09, 2025 (GLOBE NEWSWIRE) -- SEGG Media Corporation (NASDAQ: SEGG, LTRYW) (“SEGG Media” or the “Company”), a leading technology company transforming the global intersection of sports, entertainment and gaming, today announced it has signed a binding Letter of Intent (“LOI”) with David Lloyd, one of the most iconic names in British and European sport and wellness. The terms of the LOI allows SEGG Media to acqu ...